KANZAWA MEDICAL RESEARCH FOUNDATION
Kanzawa Medical Research Foundation promotes the development of healthcare and medical science by encouraging studies.
KANZAWA MEDICAL RESEARCH FOUNDATION
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
1997-06-27
Address:
Matsumoto, Nagano, Japan
Country:
Japan
Website Url:
http://www.kissei.co.jp
Total Employee:
1+
Status:
Active
Contact:
0263-25-9644
Email Addresses:
[email protected]
More informations about "Kanzawa Medical Research Foundation"
About Kissei | English Home | KISSEI …
Kissei Pharmaceutical Co., Ltd. Message. Contribute to the health of people around the world through innovative pharmaceutical products.See details»
English Home | KISSEI PHARMACEUTICAL CO.,LTD.
Sep 24, 2024 Kissei Introduces Analysis and Preparative Purification Platform for Small Molecules; September 24, 2024. Succession of Manufacturing and Marketing Authorization for MARIZEV®, Diabetes Treatment; Topics. More. …See details»
KISSEI’s Company Profile - ジェトロ（日本貿易振興機構）
Operational Organization 4 Sales Force: 10 Sales Branches 50 Offices Joetsu Chemical Laboratory Tokyo Main Offices: Nihonbashi, Koishikawa Matsumoto Area Headquarters …See details»
Kissei - Wikipedia
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include: [1] Difelikefalin; Fostamatinib (trade name …See details»
Kissei Pharmaceutical Co., Ltd. - Drug pipelines, Patents ... - Patsnap
Nov 1, 2024 Kissei Pharmaceutical Co., Ltd. specializes in the research, production, and distribution of pharmaceuticals and health foods. The company operates in three primary …See details»
KISSEI Company Profile - ジェトロ（日本貿易振興機構）
Kissei China Korea Taiwan KNV-0969 JP Preclinical Neurokinin 1 receptor antagonist/ Chronic pruritus Kissei Global12 Seeking Partners. Looking Towards Tomorrow’s Health Kissei …See details»
Organization | Kissei Pharmaceuticals - Purdue University
Kissei Pharmaceuticals Report issue For profit Phase 2 Phase 3 Phase 4 Founded: Matsumoto Japan (1946)See details»
KISSEI PHARMACEUTICAL CO., LTD. | Member Companies | Japan ...
This page is a KISSEI PHARMACEUTICAL CO., LTD. page of JPMA. Address: 19-48 Yoshino, Matsumoto, Nagano 399-8710. Contact: Phone：+81-263-25-9081See details»
Company Kissei Pharmaceutical Co., Ltd. Deutsche Boerse AG
Sep 30, 2005 KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in …See details»
Our Business | About Kissei - KISSEI PHARMACEUTICAL …
These words have been passed down at Kissei ever since the company was founded. They show that R&D is an essential and central part of our work, The phrase also expresses the passion of each and every Kissei employee for the …See details»
Kissei Pharmaceutical - Crunchbase Investor Profile & Investments
Kissei Pharmaceutical is a food company. View contacts for Kissei Pharmaceutical to access new leads and connect with decision-makers.See details»
Kissei Pharmaceutical Co., Ltd. - Overview, News & Similar
Jun 16, 2022 Who is Kissei Pharmaceutical Co., Ltd. Kissei is a Japanese pharmaceutical company based on the management philosophy "contributing to society through high-quality, …See details»
Kissei America Inc. (Merged From Kissei Comtec Co., Ltd. And …
Kissei America Inc. (Merged From Kissei Comtec Co., Ltd. And Kissei Pharma USA) VentureRadar profile. Find out more about Kissei America Inc. (Merged From Kissei Comtec …See details»
Looking Towards Tomorrow’s Health - キッセイ薬品工業株式会社
2004 Kissei America, Inc., established 2006 Mitiglinide (Japanese name: Glufast®) launched in South Korea 2007 Joetsu Chemical Laboratory constructed (Joetsu, Niigata) 2009 Silodosin …See details»
KSP-0243 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 KSP-0243, Initially developed by Kissei Pharmaceutical Co., Ltd., Now, its global highest R&D status is Phase 2, Therapeutic Areas: Digestive System Disorders, Active ...See details»
Annual Report | Investor Relations | English Home | KISSEI ...
Kissei Pharmaceutical Co., Ltd. Annual Report 2024 Annual Report (pdf 3.2 MB). Financial Data Book 2024 Financial Data Book (pdf 474.9 KB). Annual Report 2023 Annual Report (pdf 2.5 …See details»
Kissei Takes Over Marizev Marketing Authorization from MSD Japan
Sep 25, 2024 Kissei Pharmaceutical succeeded the Japanese marketing authorization for MSD’s once weekly DPP-4 inhibitor Marizev (omarigliptin), effective September 24. In Japan, …See details»
Kissei Announces New President and COO
Apr 22, 2022 Kissei will further strengthen and enhance its management foundation in order to fulfill its responsibilities as a company that is continuously listed on the Tokyo Stock Exchange …See details»
Investor Relations - KISSEI PHARMACEUTICAL CO.,LTD.
Terms of Use; Privacy Policy; Cookie Settings © 2012- Kissei Pharmaceutical Co., Ltd. All rights reserved.See details»